DiPaolo Dominick 4
4 · Matinas BioPharma Holdings, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
DiPaolo Dominick
Senior VP of Compliance
Transactions
- Award
Option (right to buy)
2017-09-28+350,000→ 350,000 totalExercise: $1.31Exp: 2027-09-28→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on September 30, 2017. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.